Collegium Pharmaceutical
COLL
46 hedge funds and large institutions have $165M invested in Collegium Pharmaceutical in 2015 Q2 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$26.7M |
| 2 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$22.9M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.8M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$13M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$12.9M |
Top Sellers
COLL Hedge Fund Activity: Q2 2015 in Review
46 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2015, worth a combined $165M.
Buyers outnumbered sellers: 46 funds opened new COLL positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $26.7M.
- 46 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $165M of Collegium Pharmaceutical stock for Q2 2015.
- 46 funds opened new Collegium Pharmaceutical positions in Q2 2015 and 0 closed out, a net change of +46 holders.
- The largest Collegium Pharmaceutical buyer in Q2 2015 was RA Capital Management, an estimated $26.7M added.
Based on aggregated 13F filings for Q2 2015.